Dr. Irnela Bajrovic received her PhD in pharmaceutical sciences from the University of Texas at Austin. Her graduate work established the viability of the thin film technology as a superior method of vaccine stabilization, which bypasses cold-chain maintenance and has the potential to simplify the transportation of biologics. Since completing her PhD, Dr. Bajrovic established and led a formulation team at a leading biotechnology company, resulting in a patent and multiple publications.